Northland Capmk Brokers Reduce Earnings Estimates for DocGo

DocGo Inc. (NASDAQ:DCGO - Free Report) - Investment analysts at Northland Capmk cut their Q2 2025 earnings per share estimates for shares of DocGo in a research note issued on Sunday, May 11th. Northland Capmk analyst M. Latimore now expects that the company will earn ($0.07) per share for the quarter, down from their prior estimate of $0.03. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.26) EPS.

Other equities analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and lowered their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a report on Monday. Needham & Company LLC lowered their target price on DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a report on Friday, May 9th. BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Stifel Nicolaus lowered their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $3.56.

DocGo Stock Performance

DocGo stock opened at $1.50 on Wednesday. DocGo has a 52 week low of $1.35 and a 52 week high of $5.68. The stock has a market capitalization of $152.97 million, a P/E ratio of 5.36, a price-to-earnings-growth ratio of 14.16 and a beta of 1.14. The stock has a fifty day moving average of $2.45 and a 200-day moving average of $3.66.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. The business had revenue of $96.03 million for the quarter, compared to analyst estimates of $104.25 million.

Institutional Investors Weigh In On DocGo

Institutional investors and hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its stake in shares of DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company's stock valued at $365,000 after buying an additional 66,097 shares during the period. Matrix Asset Advisors Inc. NY acquired a new stake in shares of DocGo in the fourth quarter valued at about $424,000. Barclays PLC increased its stake in shares of DocGo by 14.5% in the fourth quarter. Barclays PLC now owns 154,456 shares of the company's stock valued at $655,000 after buying an additional 19,533 shares during the period. Vanguard Group Inc. increased its stake in shares of DocGo by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company's stock valued at $21,261,000 after buying an additional 14,454 shares during the period. Finally, Rhumbline Advisers increased its stake in shares of DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock valued at $605,000 after buying an additional 6,204 shares during the period. Institutional investors and hedge funds own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.